Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.

Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Cough sounds carry disease-specific acoustic signatures. By analysing these signatures using an AI-based algorithm, the ...

Results showed that a dry powder inhaler loaded with umeclidinium and vilanterol produced a 14% lower risk of moderate or severe COPD flare-ups, compared to a metered-dose inhaler loaded with ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...

For four additional disease-free years, participants could tack on an average 24 extra minutes of sleep per night, about four ...

Vitality Medical reports that a state analysis shows respiratory care demand varies widely, with the South having high burden ...

Expect a high of 30 degrees that feels more like 17, with an overnight low of 21. Forecasters predict it will be not as cold ...

There will be moderate snow during the day, forecasters from AccuWeather predict, with 2.48 inches of snow likely. Throughout ...